Personal information

Verified email addresses

Radiopharmaceuticals, PET, Hypoxia, Nuclear medicine, Cancer, Physics, Chemistry
Norway

Activities

Employment (6)

St. Olavs Hospital, Trondheim University Hospital: Trondheim, NO

2023-03 to present | Physicist (Department of Radiology and Nuclear Medicine)
Employment
Source: Self-asserted source
Tengzhi Liu

Norwegian University of Science and Technology: Trondheim, NO

2019-01-01 to 2023-01-31 | PhD (Department of Physics)
Employment
Source: Self-asserted source
Tengzhi Liu

Norwegian University of Science and Technology: Trondheim, NO

2018-07 to 2018-12 | Scientific Assistant (Department of Physics)
Employment
Source: Self-asserted source
Tengzhi Liu

Norwegian University of Science and Technology: Trondheim, NO

2017-06-06 to 2017-07-21 | Research Assistant (Department of Chemical Engineering)
Employment
Source: Self-asserted source
Tengzhi Liu

University of Denver: Denver, CO, US

2014-09 to 2015-08 | Research Assistant (Department of Chemistry and Biochemistry)
Employment
Source: Self-asserted source
Tengzhi Liu

University of Denver: Denver, CO, US

2014-09 to 2015-08 | Tutor (Learning Effectiveness Program)
Employment
Source: Self-asserted source
Tengzhi Liu

Education and qualifications (4)

Norwegian University of Science and Technology: Trondheim, NO

2019-01-01 to 2023-01-31 | PhD (Department of Physics)
Education
Source: Self-asserted source
Tengzhi Liu

Norwegian University of Science and Technology: Trondheim, NO

2016-08 to 2018-06 | MSc. (Department of Chemistry)
Education
Source: Self-asserted source
Tengzhi Liu

Københavns Universitet Det Natur- og Biovidenskabelige Fakultet: Copenhagen, DK

2015-09 to 2016-06 (Department of Chemistry)
Education
Source: Self-asserted source
Tengzhi Liu

University of Denver: Denver, CO, US

2015-03-15 | B. Sc. in Chemistry (Department of Chemistry and Biochemistry)
Education
Source: Self-asserted source
Tengzhi Liu

Funding (1)

Development of Cu-64 radiopharmaceuticals for positron emission tomography (PET) imaging and treatment of hypoxic, aggressive cancer

2019-01-01 to present | Grant
Central Norway Regional Health Authority (Stjørdal, NO)
GRANT_NUMBER: 90404800
Source: Self-asserted source
Tengzhi Liu via DimensionsWizard

Works (4)

In vitro and in vivo characterization of [64Cu][Cu(elesclomol)] as a novel theranostic agent for hypoxic solid tumors

European Journal of Nuclear Medicine and Molecular Imaging
2023-10 | Journal article
Contributors: Tengzhi Liu; Maria Aanesland Dahle; Mathilde Hirsum Lystad; Laure Marignol; Morten Karlsen; Kathrine Røe Redalen
Source: check_circle
Crossref

Development of an automated production process of [64Cu][Cu (ATSM)] for positron emission tomography imaging and theranostic applications

Journal of Labelled Compounds and Radiopharmaceuticals
2022-06-15 | Journal article
Contributors: Tengzhi Liu; Kathrine Røe Redalen; Morten Karlsen
Source: check_circle
Crossref

Hypoxia imaging and theranostic potential of [64Cu][Cu(ATSM)] and ionic Cu(II) salts: a review of current evidence and discussion of the retention mechanisms

EJNMMI Research
2020-04-09 | Journal article
Part of ISSN: 2191-219X
Contributors: Tengzhi Liu; Morten Karlsen; Anna Maria Karlberg; Kathrine Røe Redalen
Source: Self-asserted source
Tengzhi Liu

Field-stepped direct detection electron paramagnetic resonance

Journal of Magnetic Resonance
2015-09 | Journal article
Contributors: Zhelin Yu; Tengzhi Liu; Hanan Elajaili; George A. Rinard; Sandra S. Eaton; Gareth R. Eaton
Source: Self-asserted source
Tengzhi Liu via Crossref Metadata Search
grade
Preferred source (of 3)‎